Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Tips from these results
- Buy BT Group (BT.A) by G A Chester in The Motley Fool
- Buy Smith (DS) (SMDS) by Bank of America
- Buy Vela Technologies (VELA) by Hot Stock Rockets in ShareProphets
- Buy Grafton Group Units (GFTU) by Berenberg
- Buy GlaxoSmithKline (GSK) by HSBC
- Underweight Victrex plc (VCT) by Morgan Stanley
- Sell Woodford Patient Capital Trust (WPCT) by Alan Oscroft in The Motley Fool
- Hold Northgate (NTG) by HSBC
- Top Pick Clinigen Group (CLIN) by RBC Capital
- Sell Lindsell Train Inv Trust (LTI) by Alan Oscroft in The Motley Fool
- Hold Ocado Group (OCDO) by Edmond Jackson in Interactive Investor
- Buy Glencore (GLEN) by HSBC
- Hold BHP Group (BHP) by HSBC
- Buy GB Group (GBG) by Berenberg
- Sell Mobile Streams (MOS) by Steve Moore in ShareProphets
- Buy BHP Group (BHP) by Peter Stephens in The Motley Fool
- Buy Reckitt Benckiser Group (RB.) by Peter Stephens in The Motley Fool
- Buy Rolls-Royce Holdings (RR.) by Peter Stephens in The Motley Fool
- Buy Gateley (Holdings) (GTLY) by Kevin Godbold in The Motley Fool
- Buy Aviva (AV.) by Peter Stephens in The Motley Fool
GlaxoSmithKline (GSK)
Health Care Sector
-
Latest quote
1,665.00p (mid)
-
Current Change (%)
1.56%
-
Price
Bid: 1,664.00p
Offer: 1,664.20p
-
Today
High: 1,672.20p
Low: 1,645.40p
-
This year
High: 1,672.20p
Low: 1,418.00p
-
Information
Volume: 4,794,572
Market Cap: £83050.2M
GlaxoSmithKline Overview
UK-based GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.GlaxoSmithKline RNS Feed
| Title | Release date |
|---|---|
| Director/PDMR Shareholding | 18:19 - July 15, 2019 |
| Director/PDMR Shareholding | 18:18 - July 15, 2019 |
| Director/PDMR Shareholding | 18:16 - July 15, 2019 |
| Director/PDMR Shareholding | 11:42 - July 15, 2019 |
| positive results in Phase 3 PRIMA study of ZEJULA | 07:00 - July 15, 2019 |
| Director/PDMR Shareholding | 16:35 - July 12, 2019 |
| Director/PDMR Shareholding | 15:55 - July 12, 2019 |
| Director/PDMR Shareholding | 15:48 - July 10, 2019 |
| ViiV switch study shows 2DR as effective as 3DR | 07:00 - July 10, 2019 |
| ViiV receives Dovato EU Marketing Authorisation | 09:00 - July 3, 2019 |
| Total Voting Rights | 12:08 - July 1, 2019 |
| Director/PDMR Shareholding | 17:10 - June 12, 2019 |
| FDA approval for Nucala self-administration | 07:00 - June 7, 2019 |
| CHMP positive on GSK's Nucala self-administration | 08:00 - June 4, 2019 |
| Total Voting Rights | 14:31 - June 3, 2019 |
NOTE: This is based on 253 open tips for this company
